Arachidonic acid and other polyunsaturated fatty acids (PUFAs) are oxidatively metabolized by cyclooxygenase, lipoxygenases, and cytochromes P450. The primary metabolites from these pathways are subject to a further cascade of transformations resulting in a rich spectrum of biologically active products. Recent studies have identified three principal sources of structural diversity and, hence, new eicosanoids: (a) multiple cytochrome P450 isoenzymes; (b) secondary metabolic routes including transformations by beta-, omega-, and keto-oxidases; reductases; conjugation to taurine, glutathione, glucuronic acid, and other small molecular weight compounds and dual pathway or transcellular oxidation; and (c) unregulated free radical processes associated with aging and/or pathophysiology that generate isoeicosanoids. The many urgent questions concerning the structure, origin, regulation, quantitation, and disposition of these eicosanoids will be addressed by (a) the isolation and structure elucidation of new eicosanoids, (b) the creation of efficient synthetic methodology and its application in unambiguous total syntheses of novel eicosanoids, (c) the preparation of selective metabolism inhibitors and eicosanoid analogs with modified stability and/or agonist/antagonist activity; (d) the development of immunoassays and instrumental assays for the detection and quantitation of eicosanoids, receptors, etc.; and (e) elucidation of the P450 active site

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM031278-20
Application #
6606134
Study Section
Bio-Organic and Natural Products Chemistry Study Section (BNP)
Program Officer
Okita, Richard T
Project Start
1983-12-01
Project End
2004-06-30
Budget Start
2003-07-01
Budget End
2004-06-30
Support Year
20
Fiscal Year
2003
Total Cost
$312,000
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Biochemistry
Type
Schools of Medicine
DUNS #
800771545
City
Dallas
State
TX
Country
United States
Zip Code
75390
Siangjong, L; Goldman, D H; Kriska, T et al. (2017) Vascular hepoxilin and trioxilins mediate vasorelaxation through TP receptor inhibition in mouse arteries. Acta Physiol (Oxf) 219:188-201
Garcia, Victor; Shkolnik, Brian; Milhau, Laura et al. (2016) 20-HETE Activates the Transcription of Angiotensin-Converting Enzyme via Nuclear Factor-?B Translocation and Promoter Binding. J Pharmacol Exp Ther 356:525-33
Garcia, Victor; Cheng, Jennifer; Weidenhammer, Adam et al. (2015) Androgen-induced hypertension in angiotensinogen deficient mice: role of 20-HETE and EETS. Prostaglandins Other Lipid Mediat 116-117:124-30
Sato, Yuka; Sato, Waichi; Maruyama, Shoichi et al. (2015) Midkine Regulates BP through Cytochrome P450-Derived Eicosanoids. J Am Soc Nephrol 26:1806-15
Jat, Jawahar L; Paudyal, Mahesh P; Gao, Hongyin et al. (2014) Direct stereospecific synthesis of unprotected N-H and N-Me aziridines from olefins. Science 343:61-5
De, Saroj Ranjan; Kumar, Ganesh; Jat, Jawahar L et al. (2014) Regio- and stereoselective monoepoxidation of dienes using methyltrioxorhenium: synthesis of allylic epoxides. J Org Chem 79:10323-33
Zhu, Chen; Falck, John R (2014) Transition-Metal-Free ipso-Functionalization of Arylboronic Acids and Derivatives. Adv Synth Catal 356:2395-2410
Nithipatikom, Kasem; Endsley, Michael P; Pfeiffer, Adam W et al. (2014) A novel activity of microsomal epoxide hydrolase: metabolism of the endocannabinoid 2-arachidonoylglycerol. J Lipid Res 55:2093-102
Zha, Weibin; Edin, Matthew L; Vendrov, Kimberly C et al. (2014) Functional characterization of cytochrome P450-derived epoxyeicosatrienoic acids in adipogenesis and obesity. J Lipid Res 55:2124-36
Sarkar, Pallabi; Zaja, Ivan; Bienengraeber, Martin et al. (2014) Epoxyeicosatrienoic acids pretreatment improves amyloid ?-induced mitochondrial dysfunction in cultured rat hippocampal astrocytes. Am J Physiol Heart Circ Physiol 306:H475-84

Showing the most recent 10 out of 362 publications